3rd Quarter - Report

IPOLICY SOLUTIONS for ASSOCIATION FOR MOLECULAR PATHOLOGY

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

No bill #, reform Sec. 101 of the Patent Act

LobbyistCovered position, as disclosed
MEGAN ANDERSON BROOKS —
JENNIFER RACHEL LEIB —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); SENATE

Medical/Disease Research/Clinical Labs MED

No bill #, Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage

LobbyistCovered position, as disclosed
MEGAN ANDERSON BROOKS —
JENNIFER RACHEL LEIB Fellow, Senate Committee on Health, Education, Labor, and Pensions

Contacted: Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Medicare coverage of next generation sequencing based tests for cancer HR4393, Advancing Access to Precision Medicine Act

LobbyistCovered position, as disclosed
MEGAN ANDERSON BROOKS —
JENNIFER RACHEL LEIB Fellow, Senate Committee on Health, Education, Labor, and Pensions

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA)

Bills named: H.R. 4393 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.